Researchers are mindful of the exciting days when new drugs raised “good” cholesterol, or HDL, but found they didn’t lower the risk of a heart attack or stroke, says Stephen Nicholls ...
A University of Iowa research team has found that a class of cholesterol-lowering drugs have no effect on kidney function.
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
The Hancock County Commission will be receiving additional funds as part of an antitrust lawsuit filed by the State of West ...
For those who can’t tolerate statins or need additional help managing cholesterol, a new drug, bempedoic acid, offers hope.
Revolutionary research shows statins combined with new PIN1 inhibitors could transform bladder cancer treatment, offering hope to thousands of patients.
New Insights About How 'Bad' Cholesterol ... Aug. 14, 2024 — More than a quarter of Australians over the age of 50 take cholesterol-lowering drugs to prevent heart disease and strokes, but ...
Salk scientists discover protein first identified at Salk in 1996 called PIN1 encourages tumor growth in bladder cancer, then ...
A combination therapy of two drugs — a statin and a protein inhibitor — may help suppress the creation and growth of tumors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results